SPAC STARRY SEA ACQUISITION CORP Announces LOI for $750M-$900M China-Based Health Acquisition Amidst Going Concern Warning

summarizeSummary

STARRY SEA ACQUISITION CORP, a blank check company, has announced a Letter of Intent (LOI) to acquire Forever Young International Limited, a China-based health industry operator, for a pre-money equity value of $750 million to $900 million. This is a critical step for the SPAC, which faces a November 7, 2026 deadline to complete a business combination or liquidate. However, the company's independent auditor has issued a 'going concern' warning, indicating substantial doubt about its ability to continue operations. Furthermore, the filing extensively details significant risks associated with a China-based acquisition, including potential regulatory intervention, data security concerns, and the risk of delisting from U.S. exchanges due to PCAOB inspection issues. Investors should weigh the positive development of a potential business combination against the severe financial and geopolitical risks highlighted.

check_boxKey Events

• Proposed Business Combination Announced

  The company entered into a Letter of Intent (LOI) on September 29, 2025, to acquire Forever Young International Limited, a health industry operator based in China.

• Significant Target Valuation

  The proposed acquisition values Forever Young International Limited at a pre-money equity value of approximately $750 million to $900 million, with consideration expected in rollover equity at $10 per share.

• Going Concern Warning Issued

  The independent registered public accounting firm's report includes an explanatory paragraph expressing substantial doubt about the company's ability to continue as a 'going concern'.

• Critical Business Combination Deadline

  The company must complete an initial business combination by November 7, 2026 (15 months from its IPO effective date) or it will be forced to liquidate its trust account.

auto_awesomeAnalysis

STARRY SEA ACQUISITION CORP, a blank check company, has announced a Letter of Intent (LOI) to acquire Forever Young International Limited, a China-based health industry operator, for a pre-money equity value of $750 million to $900 million. This is a critical step for the SPAC, which faces a November 7, 2026 deadline to complete a business combination or liquidate. However, the company's independent auditor has issued a 'going concern' warning, indicating substantial doubt about its ability to continue operations. Furthermore, the filing extensively details significant risks associated with a China-based acquisition, including potential regulatory intervention, data security concerns, and the risk of delisting from U.S. exchanges due to PCAOB inspection issues. Investors should weigh the positive development of a potential business combination against the severe financial and geopolitical risks highlighted.